查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813446

2032 年男性更年期支持市場預測：按產品類型、治療方法、給藥途徑、疾病、分銷管道和地區進行的全球分析

Male Menopause Support Market Forecasts to 2032 - Global Analysis By Product Type, Therapy Approach, Route of Administration, Disease, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球男性更年期支持市場預計在 2025 年達到 12.8 億美元，預計到 2032 年將達到 20.1 億美元，預測期內的複合年成長率為 6.7%。

男性更年期支持是指旨在控制與老齡化相關的睪固酮水平下降（通常稱為男性更年期）相關症狀的臨床和生活方式干涉措施。此類支持可能包括荷爾蒙補充療法（用於緩解疲勞、情緒變化、性慾下降和肌肉萎縮）、心理諮商、營養指導和運動療法。其目標是改善生活品質、恢復荷爾蒙平衡並降低相關的健康風險。由於症狀的嚴重程度和潛在病因因人而異，因此個人化治療至關重要。

大眾對男性健康和老齡化的認知不斷提高

公眾意識宣傳活動、名人代言和媒體報導正在鼓勵男性尋求與男性更年期相關症狀的幫助。這種轉變推動了對標靶治療的需求，包括睾酮替代療法和心理干預。此外，醫療保健提供者擴大接受專門針對男性的健康計劃，這反映出人們越來越接受與老齡化相關的挑戰。關於疲勞、情緒變化和性健康的對話逐漸正常化，正在推動市場擴張。

缺乏醫療意識，症狀不明確、特異性

易怒、性慾減退和睡眠障礙等症狀常與其他疾病重疊，使診斷更加複雜。缺乏標準化的診斷標準，且醫學課程的納入有限，進一步阻礙了執業醫師對此類疾病的認知。此外，許多男性由於恥辱感以及將症狀錯誤地歸咎於生活方式因素而推遲尋求幫助。這種診斷的不確定性限制了早期療育，並延緩了專門支持措施的採用。

對自然和整體解決方案的需求不斷成長

草藥補充劑、適應原和基於生活方式的干涉措施在尋求更安全、長期解決方案的老年男性中越來越受歡迎。該市場正在見證植物來源睪固酮增強劑、針灸通訊協定和綜合健康計劃的創新。各公司也正在投資針對荷爾蒙健康的個人化營養和健身。這一趨勢與更廣泛的預防性護理和自我管理老齡化運動相吻合，為整體產品系列鋪平了道路。

科學和醫學懷疑論

批評人士認為，與老齡化相關的荷爾蒙下降是一個自然過程，除非出現臨床顯著症狀，否則無需干預。這種懷疑態度影響了保險覆蓋範圍、監管核准以及醫生的處方行為。此外，臨床試驗結果的不一致以及對荷爾蒙療法長期安全性的擔憂加劇了人們的猶豫。這種阻力可能會減緩創新，並限制市場在保守的醫療體系中擴張的能力。

COVID-19的影響：

疫情對男性更年期支持市場產生了雙重影響。一方面，供應鏈中斷和麵對面諮詢的減少，導致診斷和治療啟動延遲。另一方面，這場危機加速了數位醫療的普及，使得遠距症狀追蹤和虛擬諮詢成為可能。居家隔離期間，男性開始更加關注自身的身心健康，對健康解決方案的興趣也隨之增加。遠端醫療平台開始提供客製化的荷爾蒙評估和治療方案，擴大了醫療服務的可近性。

預測期內，荷爾蒙補充療法(HRT) 細分市場預計將成為最大的細分市場

荷爾蒙補充療法(HRT) 領域預計將在預測期內佔據最大的市場佔有率，這得益於其在治療睪固酮缺乏症方面已得到證實的有效性。經皮吸收貼片、凝膠和鼻噴霧等給藥方式的創新提高了患者的依從性，並最大限度地減少了副作用。監管機構完善了 HRT 的使用指南，增強了醫生的信心，並擴大了臨床應用。該領域受益於強大的臨床研究和消費者日益成長的積極應對荷爾蒙失衡的意願。

預計心理諮商領域在預測期內的複合年成長率最高。

心理諮商領域預計將在預測期內實現最高成長率，反映出老年男性對心理健康的日益重視。認知行為療法、支持小組和壓力管理計畫正在被整合到綜合護理模式中。數位平台使諮詢服務的可擴展性成為可能，並使其在城市以外的地區也能獲得。圍繞男性心理脆弱的污名化正逐漸消退，促使更多男性尋求心理支持。

佔比最大的地區：

由於先進的醫療基礎設施和強大的消費者意識，北美預計將在預測期內佔據最大的市場佔有率。該地區擁有提供男性健康計畫的專業診所，並在荷爾蒙療法領域積極進行藥物研發。睾酮替代療法和心理健康服務的保險覆蓋率更高，這支撐了市場滲透。此外，對與老齡化相關的健康問題的文化開放性也推動了早期採用支持性解決方案。

複合年成長率最高的地區：

由於人口結構變化和醫療保健投資的增加，預計亞太地區將在預測期內實現最高的複合年成長率。在中國、印度和韓國等國家，男性人口正在迅速老化，這增加了對特定年齡層干預措施的需求。阿育吠陀和傳統中醫等傳統治療體係正在與現代治療方法結合，形成一種混合治療模式。政府為促進男性健康和普及數位醫療所採取的措施正在推動市場擴張。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球男性更年期支持市場（依產品類型）

  • 荷爾蒙補充療法（HRT）
    • 睾酮替代療法
    • 睪酮凝膠和乳膏
    • 注射
    • 貼片和顆粒
    • DHEA補充劑
  • 營養補充品
    • 維生素補充劑
    • 礦物質補充劑
    • 草藥補充劑
    • 多營養支持配方
  • 製藥
  • 其他產品類型

6. 全球男性更年期支持市場（依治療方法）

  • 生活方式的改變
  • 荷爾蒙療法
  • 心理諮商
  • 替代醫學
  • 其他治療方法

7. 全球男性更年期支持市場（依給藥途徑）

  • 口服
  • 腸外
  • 經皮
  • 皮下

第8章全球男性更年期支持市場（按疾病）

  • 男性性腺功能低下症
  • 勃起功能障礙
  • 性慾下降
  • 老年男性雄性激素下降
  • 其他疾病

9. 全球男性更年期支持市場（依通路）

  • 健康與保健商店
  • 網路藥局和電子商務
  • 零售藥局和藥局
  • 醫院藥房
  • 直接面對消費者（DTC）
  • 其他分銷管道

第10章全球男性更年期支持市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • AbbVie Inc.
  • Pfizer Inc.
  • Bayer AG
  • Eli Lilly and Company
  • Sun Pharmaceuticals Industries Ltd.
  • Novo Nordisk A/S
  • Merck & Co., Inc.
  • Renuva HRT & Wellness
  • TherapeuticsMD, Inc.
  • Marion Gluck Clinic
  • Health & Her
  • Zora Health
  • Halozyme Therapeutics, Inc.
  • Perrigo Company plc
  • Novartis AG
  • Endo International plc
  • Ferring Pharmaceuticals
  • Mylan NV
Product Code: SMRC30895

According to Stratistics MRC, the Global Male Menopause Support Market is accounted for $1.28 billion in 2025 and is expected to reach $2.01 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Male menopause support is the clinical and lifestyle interventions designed to manage symptoms associated with age-related testosterone decline, commonly termed andropause. This support may include hormone replacement therapy, psychological counseling, nutritional guidance, and exercise regimens to address fatigue, mood changes, reduced libido, and muscle loss. It aims to improve quality of life, restore hormonal balance, and mitigate associated health risks. Tailored approaches are essential, as symptom severity and underlying causes vary among individuals

Market Dynamics:

Driver:

Increasing public discourse around men's health and aging

Public awareness campaigns, celebrity endorsements, and media coverage are encouraging men to seek support for symptoms linked to andropause. This shift is fostering demand for targeted therapies, including testosterone replacement and psychological interventions. Moreover, healthcare providers are increasingly integrating male-specific wellness programs, reflecting a broader cultural acceptance of aging-related challenges. The normalization of conversations around fatigue, mood changes, and sexual health is catalyzing market expansion.

Restraint:

Lack of medical recognition & vague, non-specific symptoms

Symptoms such as irritability, low libido, and sleep disturbances often overlap with other conditions, making diagnosis complex. The absence of standardized diagnostic criteria and limited inclusion in medical curricula further hinder recognition among practitioners. Additionally, many men delay seeking help due to stigma or misattribution of symptoms to lifestyle factors. This diagnostic uncertainty restricts early intervention and slows adoption of specialized support solutions.

Opportunity:

Growing demand for natural and holistic solutions

Herbal supplements, adaptogens, and lifestyle-based interventions are gaining traction among aging men seeking safer, long-term solutions. The market is witnessing innovation in plant-based testosterone boosters, acupuncture protocols, and integrative wellness programs. Companies are also investing in personalized nutrition and fitness platforms tailored to hormonal health. This trend aligns with the broader movement toward preventive care and self-managed aging, opening avenues for holistic product portfolios.

Threat:

Scientific and medical skepticism

Critics argue that age-related hormonal decline is a natural process, not requiring intervention unless clinically severe. This skepticism affects insurance coverage, regulatory approvals, and physician prescribing behavior. Furthermore, inconsistent clinical trial outcomes and concerns over long-term safety of hormone therapies contribute to hesitancy. Such resistance may slow innovation and limit the market's ability to scale across conservative healthcare systems.

Covid-19 Impact:

The pandemic had a dual impact on the male menopause support market. On one hand, disruptions in supply chains and reduced in-person consultations delayed diagnoses and treatment initiation. On the other, the crisis accelerated digital health adoption, enabling remote symptom tracking and virtual counseling. Men became more attuned to their mental and physical health during lockdowns, prompting increased interest in wellness solutions. Telemedicine platforms began offering tailored hormonal assessments and therapy plans, expanding access to care.

The hormone replacement therapy (HRT) segment is expected to be the largest during the forecast period

The hormone replacement therapy (HRT) segment is expected to account for the largest market share during the forecast period due to its established efficacy in managing testosterone deficiency. Innovations in delivery formats such as transdermal patches, gels, and nasal sprays are improving patient adherence and minimizing side effects. Regulatory bodies are refining guidelines for HRT use, enhancing physician confidence and expanding its clinical application. The segment benefits from robust clinical research and growing consumer willingness to address hormonal imbalances proactively.

The psychological counseling segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the psychological counseling segment is predicted to witness the highest growth rate reflecting the rising emphasis on mental health in aging men. Cognitive behavioral therapy, support groups, and stress management programs are being integrated into comprehensive care models. Digital platforms are enabling scalable delivery of counseling services, making them accessible beyond urban centers. The stigma around male emotional vulnerability is gradually eroding, encouraging more men to seek psychological support.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by advanced healthcare infrastructure and high consumer awareness. The region has a strong presence of specialized clinics offering male wellness programs, alongside active pharmaceutical R&D in hormone therapies. Insurance coverage for testosterone replacement and mental health services is more prevalent, supporting market penetration. Additionally, cultural openness toward aging-related health issues fosters early adoption of support solutions.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by demographic shifts and increasing healthcare investments. Countries like China, India, and South Korea are witnessing a surge in aging male populations, prompting demand for age-specific interventions. Traditional medicine systems such as Ayurveda and Traditional Chinese Medicine are being integrated with modern therapies, creating hybrid treatment models. Government initiatives promoting men's health and digital healthcare access are accelerating market expansion.

Key players in the market

Some of the key players in Male Menopause Support Market include AbbVie Inc., Pfizer Inc., Bayer AG, Eli Lilly and Company, Sun Pharmaceuticals Industries Ltd., Novo Nordisk A/S, Merck & Co., Inc., Renuva HRT & Wellness, TherapeuticsMD, Inc., Marion Gluck Clinic, Health & Her, Zora Health, Halozyme Therapeutics, Inc., Perrigo Company plc, Novartis AG, Endo International plc, Ferring Pharmaceuticals, and Mylan N.V.

Key Developments:

In May 2025, Sun Pharma announced completion of its acquisition of Checkpoint Therapeutics, Inc., expanding its oncology and specialty portfolio. The company also published Q4/FY results in May and management updates tied to integration and future pipeline plans.

In May 2025, Pfizer entered an exclusive global (ex-China) licensing agreement with 3SBio to develop, manufacture and commercialize SSGJ-707, a PD-1/VEGF bispecific currently in China trials. The deal gives Pfizer global rights outside China and includes options on China commercialization; Pfizer emphasized oncology pipeline expansion.

In May 2025, AbbVie announced FDA accelerated approval of EMRELIS(TM) (telisotuzumab vedotin-tllv) for adults with previously treated advanced non-small-cell lung cancer (NSCLC) with high c-Met protein overexpression.

Product Types Covered:

  • Hormone Replacement Therapy (HRT)
  • Dietary Supplements
  • Pharmaceuticals
  • Other Product Types

Therapy Approaches Covered:

  • Lifestyle Modifications
  • Hormonal Therapy
  • Psychological Counseling
  • Alternative Medicine
  • Other Therapy Approaches

Route of Administrations Covered:

  • Oral
  • Parenteral
  • Transdermal
  • Subcutaneous

Diseases Covered:

  • Male Hypogonadism
  • Erectile Dysfunction
  • Loss of Libido
  • Androgen Decline in the Aging Male
  • Other Diseases

Distribution Channels Covered:

  • Health & Wellness Stores
  • Online Pharmacies & E-commerce
  • Retail Pharmacies & Drug Stores
  • Hospital Pharmacies
  • Direct-to-Consumer (DTC) Sales
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Male Menopause Support Market, By Product Type

  • 5.1 Introduction
  • 5.2 Hormone Replacement Therapy (HRT)
    • 5.2.1 Testosterone Replacement Therapy
    • 5.2.2 Testosterone Gels & Creams
    • 5.2.3 Injections
    • 5.2.4 Patches & Pellets
    • 5.2.5 DHEA Supplements
  • 5.3 Dietary Supplements
    • 5.3.1 Vitamin Supplements
    • 5.3.2 Mineral Supplements
    • 5.3.3 Herbal Supplements
    • 5.3.4 Multi-nutrient Support Formulas
  • 5.4 Pharmaceuticals
  • 5.5 Other Product Types

6 Global Male Menopause Support Market, By Therapy Approach

  • 6.1 Introduction
  • 6.2 Lifestyle Modifications
  • 6.3 Hormonal Therapy
  • 6.4 Psychological Counseling
  • 6.5 Alternative Medicine
  • 6.6 Other Therapy Approaches

7 Global Male Menopause Support Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Parenteral
  • 7.4 Transdermal
  • 7.5 Subcutaneous

8 Global Male Menopause Support Market, By Disease

  • 8.1 Introduction
  • 8.2 Male Hypogonadism
  • 8.3 Erectile Dysfunction
  • 8.4 Loss of Libido
  • 8.5 Androgen Decline in the Aging Male
  • 8.6 Other Diseases

9 Global Male Menopause Support Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Health & Wellness Stores
  • 9.3 Online Pharmacies & E-commerce
  • 9.4 Retail Pharmacies & Drug Stores
  • 9.5 Hospital Pharmacies
  • 9.6 Direct-to-Consumer (DTC) Sales
  • 9.7 Other Distribution Channels

10 Global Male Menopause Support Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 AbbVie Inc.
  • 12.2 Pfizer Inc.
  • 12.3 Bayer AG
  • 12.4 Eli Lilly and Company
  • 12.5 Sun Pharmaceuticals Industries Ltd.
  • 12.6 Novo Nordisk A/S
  • 12.7 Merck & Co., Inc.
  • 12.8 Renuva HRT & Wellness
  • 12.9 TherapeuticsMD, Inc.
  • 12.10 Marion Gluck Clinic
  • 12.11 Health & Her
  • 12.12 Zora Health
  • 12.13 Halozyme Therapeutics, Inc.
  • 12.14 Perrigo Company plc
  • 12.15 Novartis AG
  • 12.16 Endo International plc
  • 12.17 Ferring Pharmaceuticals
  • 12.18 Mylan N.V

List of Tables

  • Table 1 Global Male Menopause Support Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Male Menopause Support Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Male Menopause Support Market Outlook, By Hormone Replacement Therapy (HRT) (2024-2032) ($MN)
  • Table 4 Global Male Menopause Support Market Outlook, By Testosterone Replacement Therapy (2024-2032) ($MN)
  • Table 5 Global Male Menopause Support Market Outlook, By Testosterone Gels & Creams (2024-2032) ($MN)
  • Table 6 Global Male Menopause Support Market Outlook, By Injections (2024-2032) ($MN)
  • Table 7 Global Male Menopause Support Market Outlook, By Patches & Pellets (2024-2032) ($MN)
  • Table 8 Global Male Menopause Support Market Outlook, By DHEA Supplements (2024-2032) ($MN)
  • Table 9 Global Male Menopause Support Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 10 Global Male Menopause Support Market Outlook, By Vitamin Supplements (2024-2032) ($MN)
  • Table 11 Global Male Menopause Support Market Outlook, By Mineral Supplements (2024-2032) ($MN)
  • Table 12 Global Male Menopause Support Market Outlook, By Herbal Supplements (2024-2032) ($MN)
  • Table 13 Global Male Menopause Support Market Outlook, By Multi-nutrient Support Formulas (2024-2032) ($MN)
  • Table 14 Global Male Menopause Support Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 15 Global Male Menopause Support Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 16 Global Male Menopause Support Market Outlook, By Therapy Approach (2024-2032) ($MN)
  • Table 17 Global Male Menopause Support Market Outlook, By Lifestyle Modifications (2024-2032) ($MN)
  • Table 18 Global Male Menopause Support Market Outlook, By Hormonal Therapy (2024-2032) ($MN)
  • Table 19 Global Male Menopause Support Market Outlook, By Psychological Counseling (2024-2032) ($MN)
  • Table 20 Global Male Menopause Support Market Outlook, By Alternative Medicine (2024-2032) ($MN)
  • Table 21 Global Male Menopause Support Market Outlook, By Other Therapy Approaches (2024-2032) ($MN)
  • Table 22 Global Male Menopause Support Market Outlook, By Route of Administration (2024-2032) ($MN)
  • Table 23 Global Male Menopause Support Market Outlook, By Oral (2024-2032) ($MN)
  • Table 24 Global Male Menopause Support Market Outlook, By Parenteral (2024-2032) ($MN)
  • Table 25 Global Male Menopause Support Market Outlook, By Transdermal (2024-2032) ($MN)
  • Table 26 Global Male Menopause Support Market Outlook, By Subcutaneous (2024-2032) ($MN)
  • Table 27 Global Male Menopause Support Market Outlook, By Disease (2024-2032) ($MN)
  • Table 28 Global Male Menopause Support Market Outlook, By Male Hypogonadism (2024-2032) ($MN)
  • Table 29 Global Male Menopause Support Market Outlook, By Erectile Dysfunction (2024-2032) ($MN)
  • Table 30 Global Male Menopause Support Market Outlook, By Loss of Libido (2024-2032) ($MN)
  • Table 31 Global Male Menopause Support Market Outlook, By Androgen Decline in the Aging Male (2024-2032) ($MN)
  • Table 32 Global Male Menopause Support Market Outlook, By Other Diseases (2024-2032) ($MN)
  • Table 33 Global Male Menopause Support Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 34 Global Male Menopause Support Market Outlook, By Health & Wellness Stores (2024-2032) ($MN)
  • Table 35 Global Male Menopause Support Market Outlook, By Online Pharmacies & E-commerce (2024-2032) ($MN)
  • Table 36 Global Male Menopause Support Market Outlook, By Retail Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 37 Global Male Menopause Support Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 38 Global Male Menopause Support Market Outlook, By Direct-to-Consumer (DTC) Sales (2024-2032) ($MN)
  • Table 39 Global Male Menopause Support Market Outlook, By Other Distribution Channels (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.